Arden Trust CO Exelixis, Inc. Transaction History

Arden Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 15, 2021	SELL	$18.39 - $24.8 $166,760 - $224,886	-9,068 Closed	0 $0
Q3 2020 Oct 15, 2020	SELL	$20.67 - $26.94 $96,156 - $125,324	-4,652 Reduced 33.91%	9,068 $222,000
Q1 2020 Apr 16, 2020	BUY	$14.46 - $21.8 $198,391 - $299,096	13,720 New	13,720 $236,000
Q4 2019 Jan 17, 2020	SELL	$15.15 - $18.89 $221,886 - $276,662	-14,646 Closed	0 $0
Q3 2019 Oct 09, 2019	SELL	$17.68 - $22.65 $477 - $611	-27 Reduced 0.18%	14,646 $259,000
Q2 2019 Jul 23, 2019	BUY	$18.93 - $24.75 $277,759 - $363,156	14,673 New	14,673 $314,000

460

240M

2.04M

1.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $8.44B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Arden Trust CO, based on Form 13F filings with the SEC.

Stay updated on Arden Trust CO with notifications on news.